IV NEWS
News and innovation - June 10, 2024
Beneath the surface: subcutaneous injection for dehydration
Risk of dehydration higher during the summer As temperatures rise during the summer months, the risk of dehydration increases. This…
Events and training June 3, 2024
How to build CVAM care bundles
It is estimated that up to 90 percent of people treated within a hospital in-patient setting receive an intravascular (IV)…
“Complications of IV catheter therapy are simply the result of one complex and highly variable mechanical system—IV catheter equipment design,...
News and innovation May 21, 2024
IV flush via prefilled saline syringes in operating theatres and ICUs
Challenges of vascular access in operating theatres and ICUs Operating theatres and intensive care units (ICUs) are hectic environments where…
News and innovation May 13, 2024
International Nurses Day: empowering nurses in vascular access
Happy International Nurses Day to all nurses out there! Nursing can sometimes be undervalued by healthcare leaders, policy makers and…
News and innovation April 29, 2024
EU Directive 2022/431: What’s in it for healthcare workers?
EU Directive 2022/431 in a nutshell European Union (EU) Directive 2022/431, also known as the Carcinogens, Mutagens and Reprotoxic Substances…
Events and training April 22, 2024
Earth Day 2024: Our planet prefers TIVA anaesthesia—do you?
Healthcare's climate footprint is equivalent to 4.4% of global net emissions; this means that if the health sector were a…
Events and training April 15, 2024
Reducing infection with catheter care bundles
Catheter-related bloodstream infections (CRBSIs) are a serious threat to patients with a vascular access device, yet many are preventable using…
Fast fact
TIVA anaesthesia
Propofol-based total intravenous anaesthesia (TIVA) emits four orders of magnitude less greenhouse gases than inhaled anaesthesia with desflurane and N2O.